Trial Profile
Effect of EPA/DHA supplementation added on DPP4 inhibitors on lipid and glucose metabolism in patients with type 2 diabetes
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 21 Apr 2015 Status changed from not yet recruiting to discontinued, according to University Hospital Medical Information Network - Japan.
- 07 Aug 2013 New trial record